Gilead Sciences
GILD
$83.35
Share price
-0.45%
Change (1 day)
21.36%
Change (1 year)
Categories
EPS for Gilead Sciences (GILD)
EPS in 2022 (TTM): $2.66
According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is $2.66. In 2021 the company made an earnings per share (EPS) of $4.95 an increase over its 2020 EPS that were of $0.10000.
EPS history for Gilead Sciences from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | $2.66 | -46.26% |
| 2021 | $4.95 | 4850% |
| 2020 | $0.10000 | -97.64% |
| 2019 | $4.24 | 0.9% |
| 2018 | $4.20 | 18.71% |
| 2017 | $3.54 | -64.88% |
| 2016 | $10.08 | -18.45% |
| 2015 | $12.36 | 55.28% |
| 2014 | $7.96 | 296.02% |
| 2013 | $2.01 | 17.89% |
| 2012 | $1.70 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $7.28 | 173.76% | 🇺🇸 USA |
 Pfizer PFE | $5.31 | 99.62% | 🇺🇸 USA |
 AbbVie ABBV | $7.58 | 185.11% | 🇺🇸 USA |
 Eli Lilly LLY | $6.48 | 143.68% | 🇺🇸 USA |
 Amgen AMGN | $12.54 | 371.43% | 🇺🇸 USA |
 Biogen BIIB | $19.68 | 639.85% | 🇺🇸 USA |
 Illumina ILMN | -$26.39 | -1,092.11% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $12.81 | 381.58% | 🇺🇸 USA |
 Merck MRK | $6.03 | 126.69% | 🇺🇸 USA |